A four-page outline of our branding and naming services.

A six-page outline of our branding and naming services personalized for pharmaceutical and life science opportunities, including our 2013 pharmaceutical trademark advisory.

A single-page advisory of our pharmaceutical naming best practices for 2013.

A single-page summary of our 2012/2013 US/FDA approved new molecular entity drug name analysis.